These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20959149)

  • 1. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation.
    Commodaro AG; Bueno V; Belfort R; Rizzo LV
    Autoimmun Rev; 2011 Feb; 10(4):205-9. PubMed ID: 20959149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
    Commodaro AG; Peron JP; Lopes CT; Arslanian C; Belfort R; Rizzo LV; Bueno V
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology in clinical practice. XIII. Immune diseases of the eye].
    Ooijman FM; van der Lelij A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
    Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
    Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis.
    Sonoda KH; Yoshimura T; Takeda A; Ishibashi T; Hamano S; Yoshida H
    Int Immunol; 2007 Jan; 19(1):93-8. PubMed ID: 17118967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis.
    Agarwal RK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1999 Mar; 162(5):2648-54. PubMed ID: 10072507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New methods of therapy for ocular inflammatory autoimmune diseases].
    Kubicka-Trzaska A; Undas A
    Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
    Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
    Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats.
    Egwuagu CE; Sztein J; Mahdi RM; Li W; Chao-Chan C; Smith JA; Charukamnoetkanok P; Chepelinsky AB
    J Immunol; 1999 Jan; 162(1):510-7. PubMed ID: 9886427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
    Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in ocular mast cell numbers and histamine distribution during experimental autoimmune uveitis.
    Lee CH; Lang LS; Orr EL
    Reg Immunol; 1993; 5(2):106-13. PubMed ID: 8217552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoreceptor mitochondrial oxidative stress in experimental autoimmune uveitis.
    Saraswathy S; Rao NA
    Ophthalmic Res; 2008; 40(3-4):160-4. PubMed ID: 18421232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of immunologic mechanisms in endogenous uveitis].
    Kubicka A
    Klin Oczna; 1995; 97(3-4):90-2. PubMed ID: 7474804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral immune response to retinal S-antigen in patients with uveitis].
    Klass M; Böhnke M; Damms T; Knospe V
    Fortschr Ophthalmol; 1991; 88(5):450-4. PubMed ID: 1757030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.